These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12054592)

  • 1. Nuclear factor (NF)-kappa B blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1 beta biosynthesis in alveolar epithelial cells.
    Haddad JJ
    Biochem Biophys Res Commun; 2002 Apr; 293(1):252-7. PubMed ID: 12054592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappa B-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis.
    Haddad JJ; Fahlman CS
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1045-51. PubMed ID: 11866471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappab blockade attenuates but does not abrogate lipopolysaccharide-dependent tumor necrosis factor-alpha biosynthesis in alveolar epithelial cells.
    Haddad JJ; Land SC
    Biochem Biophys Res Commun; 2001 Jul; 285(2):267-72. PubMed ID: 11444836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
    Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
    Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
    J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant TNF-alpha mediated regulation of the I kappa B-alpha/NF-kappa B signaling pathway: evidence for the enhancement of pro- and anti-inflammatory cytokines in alveolar epithelial cells.
    Haddad JJ
    Cytokine; 2002 Mar; 17(6):301-10. PubMed ID: 12061837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of gamma-glutamylcysteine synthetase, augments LPS-mediated pro-inflammatory cytokine biosynthesis: evidence for the implication of an IkappaB-alpha/NF-kappaB insensitive pathway.
    Haddad JJ
    Eur Cytokine Netw; 2001; 12(4):614-24. PubMed ID: 11781188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
    Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
    Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new structural class of proteasome inhibitors that prevent NF-kappa B activation.
    Lum RT; Kerwar SS; Meyer SM; Nelson MG; Schow SR; Shiffman D; Wick MM; Joly A
    Biochem Pharmacol; 1998 May; 55(9):1391-7. PubMed ID: 10076530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
    Haddad JJ
    Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA; Owens MW; Grisham MB
    Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
    Fiedler MA; Wernke-Dollries K; Stark JM
    Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox signaling-mediated regulation of lipopolysaccharide-induced proinflammatory cytokine biosynthesis in alveolar epithelial cells.
    Haddad JJ; Land SC
    Antioxid Redox Signal; 2002 Feb; 4(1):179-93. PubMed ID: 11970852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium.
    Haddad JJ; Land SC
    Am J Respir Cell Mol Biol; 2002 Jan; 26(1):114-26. PubMed ID: 11751211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B regulates the LPS-induced expression of interleukin 12 p40 in murine peritoneal macrophages: roles of PKC, PKA, ERK, p38 MAPK, and proteasome.
    Zhang JS; Feng WG; Li CL; Wang XY; Chang ZL
    Cell Immunol; 2000 Aug; 204(1):38-45. PubMed ID: 11006016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells.
    Haddad JJ; Land SC; Tarnow-Mordi WO; Zembala M; Kowalczyk D; Lauterbach R
    J Pharmacol Exp Ther; 2002 Feb; 300(2):567-76. PubMed ID: 11805218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.
    Meyer S; Kohler NG; Joly A
    FEBS Lett; 1997 Aug; 413(2):354-8. PubMed ID: 9280312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.
    Cobb RR; Felts KA; Parry GC; Mackman N
    Eur J Immunol; 1996 Apr; 26(4):839-45. PubMed ID: 8625976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.